NervGen Pharma Corp. Common stock

Line items

• Revenue
• Cost Of Revenue
• Gross Profit
• Research And Development Expenses
• Selling General And Administrative Expenses
• Other Expenses
• Operating Expenses
• Cost And Expenses
• Interest Income
• Interest Expense
• Depreciation And Amortization
• Ebitda
• Operating Income
• Total Other Income Expenses Net
• Income Before Tax
• Income Tax Expense
• Net Income
• Weighted Average Shs Out
• Weighted Average Shs Out Dil

Line items

• Cash And Short Term Investments
• Net Receivables
• Inventory
• Total Current Assets
• Property Plant Equipment Net
• Goodwill And Intangible Assets
• Long Term Investments
• Total Non Current Assets
• Total Assets
• Account Payables
• Short Term Debt
• Deferred Revenue
• Total Current Liabilities
• Long Term Debt
• Deferred Revenue Non Current
• Total Non Current Liabilities
• Capital Lease Obligations
• Total Liabilities
• Common Stock
• Retained Earnings
• Accumulated Other Comprehensive Income Loss
• Total Equity
• Total Investments
• Total Debt
• Net Debt

Line items

• Net Income
• Depreciation And Amortization
• Stock Based Compensation
• Change In Working Capital
• Accounts Receivables
• Inventory
• Accounts Payables
• Net Cash Provided By Operating Activities
• Investments In Property Plant And Equipment
• Acquisitions Net
• Net Cash Used For Investing Activites
• Common Stock Issued
• Common Stock Repurchased
• Dividends Paid
• Net Cash Used Provided By Financing Activities
• Net Change In Cash
• Cash At End Of Period
• Operating Cash Flow
• Capital Expenditure
• Free Cash Flow